Compound ID | 153
CAL02
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; Antivirulence; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Traps and neutralizes bacterial toxins |
| Target Pathogen: | Active against Staphylococcus aureus |
| Combined with other compounds: | Yes |
| Description: | Nanoparticles in liposomes; an antitoxin agent |
| Institute where first reported: | LASCCO, Switzerland |
| Year first mentioned: | 2013 |
| Highest development stage: | Phase 2 (NCT05776004) |
| Development status: | Active (as of 2025) |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.